![](https://investorshub.advfn.com/uicon/486527.png?cb=1571677899)
Thursday, September 17, 2020 5:09:47 PM
The CEO MUST get shareholder & SEC approval ETC as specified here UNLIKE what many thought.
Best read is here:
https://budgeting.thenest.com/reverse-stock-split-rules-22480.html
ALSO:
UNLIKE what many presuppose.....
Despite NWBO recent ascent it does not have a five consecutive days of price advance unlike these others: Notably nGBM Approved Novocure which has been railed prominently against especially by Flipper & Sentiment and MANY others since late May 2019 in the high $40's:
NVCR hit all time high today $111; where if one shorted or even bought a Put Option: LOSE ALL your money
The other two notables on that less than 200
stocks on ALL exchanges that did have 5 up days were IMMU and INMB!
Although NWBO has had a great run recently it got close with 4 up days.. but not five.
ALL need to do their own Due Diligence to VERIFY!
Glad I always follow my sixth sense as well as tracking with what CEO Linda Powers has been all about which few give very little FOREthought to since 2014! (one needs to understand the MYRIAD of forces at play!) instead of all too often incessant repetitious backlash, whether on this, or any message board or when I am competing against Wall St titans.
Morale of above:
Venturing out of one's so called expertise, really inexperience has most definitely roilled lots of folks here financially!
DIFFERENT STROKES FOR DIFFERENT FOLKS
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM